Top Core and Group Health Stories
GLP-1 obesity and diabetes drugs drive 17% of employee pharmacy claims, CBIZ reports
By Allison BellThe firm's benefits clients spent three times more on the drugs last year than in 2022.
News, insight, and analysis from industry experts to help benefits brokers, consultants and advisors make their way through the tumultuous reformed health care marketplace. Content will help them grow their practices by focusing on a wide range of products, discussing new sales and marketing strategies and highlighting innovative and disruptive brokers who are forging a new path in today's benefits marketplace.
The firm's benefits clients spent three times more on the drugs last year than in 2022.